Plasmapheresis and immunopathogenetic aspects of toxic epidermal necrolysis;Plasmapherese und immunpathogenetische Aspekte bei der toxischen epidermalen Nekrolyse

Hautarzt

Volumn 47, Issue 10, 1996, Pages 749-753

  Hermes, Barbara ^a   Haas, Norbert ^a   Henz, Beate M ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Lyell syndrome; lymphocyte; macrophages; plasmapheresis; TEN; TNF

Indexed keywords

CD8 ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

AGED; ARTICLE; CASE REPORT; FEMALE; HUMAN; LYMPHOCYTE; MACROPHAGE; PLASMAPHERESIS; TOXIC EPIDERMAL NECROLYSIS;

AGED; AGED, 80 AND OVER; CD8-POSITIVE T-LYMPHOCYTES; CYTOTOXICITY, IMMUNOLOGIC; EPIDERMAL NECROLYSIS, TOXIC; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; HUMANS; IMMUNOENZYME TECHNIQUES; MACROPHAGES; PLASMAPHERESIS; SKIN; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0029812153     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001050050502     Document Type: Article

References (30)

1. Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau JG (1993) Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol 129: 92-96
2. Correia O, Delgado L, Ramos JP, Resende C, Fleming Torrinha JA (1992) Cutaneous T-cell recruitment in toxic epidermal necrolysis. Arch Dermatol 129: 466-468
3. Davatdarova MM (1990) Plazmaferez v terapii lekarstvenani toksidermii. Vestn Dermatol Venerol 7: 32-34
4. Grattan CEH, Francis DM, Slater NGP, Barlow RJ, Greaves MW (1992) Plasmapheresis for severe, unremitting, chronic urticaria. Lancet I:1078-1080
5. Halebian PH, Corder VJ, Madden MR et al. (1986) Improved burn center survival of patients with toxic epidermal necrolysis managed without corticosteroids. Ann Surg 204: 503-512
6. Heng MCY, Alen SG (1991) Efficacy of cyclophosphamide in toxic epidermal necrolysis. J Am Acad Dermatol 25: 778-786
7. Hensen EJ, Claas FHJ, Veermer BJ (1981) Drug-dependent binding of circulating antibodies in drug-induced toxic epidermal necrolysis. Lancet II: 151-152
8. Hewitt J, Omerod AD (1992) Toxic epidermal necrolysis treated with cyclosporin. Clin Exp Dermatol 17: 264-265
9. Kamanabroo D, Schmitz-Landgraf W, Czarnetzki EM (1985) Plasmapheresis in severe drug-induced toxic epidermal necrolysis. Arch Dermatol 121: 1548-1549
10. Leserbrief und redaktionelle Antwort (1993) Plasmapherese bei toxischer epidermaler Nekrolyse (TEN). Arzneimittelbrief 27: 56
11. Merot Y, Gravallese E, Guillén FJ, Murphy GF (1986) Lymphocyte subsets and Langerhans' cells in toxic epidermal necrolysis. Arch Dermatol 122: 455-458
12. Miyauchi H, Hosokawa H, Akaeda T, Iba H, Asada Y (1991) T-cell subsets in drug-induced toxic epidermal necrolysis. Arch Dermatol 127: 851-855
13. Paquet P, Nikkels A, Arrese JE, Vanderkelen A, Priérard GE (1994) Macrophages and tumor necrosis factor α in toxic epidermal necrolysis. Arch Dermatol 130: 605-608
14. Patterson R, Miller M, Kaplan M, Doan T, Brown J, Detjen P, Grammer LC, Greenberger PA, Hogan MB, Latall J, Lowenthal M, Pongracic J, Sonenthal K, Zeiss CR (1994) Effectiveness of early therapy with corticosteroids in Stevens-Johnson syndrome: experience with 41 cases and a hypothesis regarding pathogenesis. Ann Allergy 73: 27-34
15. Piguet PF, Grau GE, Allet B et al. (1987) Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease. J Exp Med 166: 1280-1289
16. Raviglione MC, Pablos-Mendez A, Battan R (1990) Clinical features and management of severe dermatological reactions to drugs. Drug Saf 5: 39-64
17. Redondo P, Ruíz de Erenchun F, Iglesias ME, Monedero P, Quintanilla E (1994) Toxic epidermal necrolysis. Treatment with pentoxifylline. Br J Dermatol 130: 688-689
18. Renfro L, Grant-Kels JM, Daman LA (1989) Drug-induced toxic epidermal necrolysis treated with cyclosporin. Int J Dermatol 28: 441-444
19. Roujeau J-C, Chosidow O, Daiag P, Guillaume J-C (1990) Toxic epidermal necrolysis (Lyell syndrome). J Am Acad Dermatol 23: 1039-1058
20. Roujeau J-C, Guillaume J-C, Fabre J-P, Penso D, Flechet ML, Girre JP (1990) Toxic epidermal necrolysis (Lyell syndrome). Incidence and drug etiology in France. Arch Dermatol 126: 37-42
21. Roujeau JC, Dubertret L, Moritz S, Jouault H, Heslan M, Revuz J, Touraine R (1985) Involvement of macrophages in the pathology of toxic epidermal necrolysis. Br J Dermatol 113: 425-430
22. Sakellariou G, Koukoudis P, Karpouzas J et al. (1991) Plasma exchange (PE) treatment in drug-induced toxic epidermal necrolysis (TEN). Int J Artif Organs 14: 634-638
23. Schöpf E, Stühmer A, Rzany B, Victor N, Zentgraf R, Kapp JF (1991) Toxic epidermal necrolysis and Stevens-Johnson syndrome. An epidemiologic study from West Germany. Arch Dermatol 127: 839-842
24. Schuchmann M, Hess S, Bufler P, Brakebusch C, Wallach D, Porter A, Riethmuller G, Engelmann H (1995) Functional discrepancies between tumor necrosis factor and lymphotoxin alpha explained by trimer stability and distinct receptor interactions. Eur J Immunol 25: 2183-2189
25. Shumak KH, Rock GA (1984) Therapeutic plasma exchange. New Engl J Med 310: 762-770
26. Tegelberg-Stassen MJ, van Vloten WA, Baart de la Faille H (1990) Management of non-staphylococcal toxic epidermal necrolysis: follow-up study of 16 case histories. Dermatologica 180: 124-129
27. van der Meché FGA, Schmitz PIM (1992) A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. N Engl J Med 326: 1123-1129
28. Ward DJ, Krzeminska EC, Tanner Ns (1990) Treatment of toxic epidermal necrolysis and a review of six cases. Burns 16: 97-104
29. Wolkenstein P, Charue D, Laurent P, Revuz J, Roujeau J-C, Bagot M (1995) Metabolic predisposition to cutaneous adverse drug reactions. Role in toxic epidermal necrolysis caused by sulfonamides and anticonvulsants. Arch Dermatol 131: 544-551
30. Wolkenstein P, Roujeau JC (1994) Epidemiology of toxic epidermal necrolysis. Eur J Dermatol 4: 175-180